Transarterial embolization (TAE)

PROCEDURE2 trials

Sponsors

National Institutes of Health Clinical Center (CC), Zhejiang Raygene Pharmaceuticals Co., Ltd

Conditions

HCCHepatic CancerHepatocellular CancerLiver CancerLiver Neoplasms

Phase 2

A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer.

RecruitingNCT06844357

Zhejiang Raygene Pharmaceuticals Co., LtdHCC

Start: 2025-03-27End: 2029-04-01Target: 300Updated: 2025-04-06

Unknown Phase

LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors

TerminatedNCT02649868

National Institutes of Health Clinical Center (CC)Hepatic Cancer, Hepatocellular Cancer, Liver Cancer +1

Start: 2016-01-12End: 2020-07-23Updated: 2024-07-11